Zhengsheng Wu

Risk model of hepatocellular carcinoma based on cuproptosis-related genes

Haibo Wang, Y. Qi, Wenyong Wu, 2022, Frontiers in Genetics.

PRDX6 knockout restrains the malignant progression of intrahepatic cholangiocarcinoma

Yuxian Shen, Qixin Chen, Hong Li, 2022, Medical Oncology.

CAF-Released Exosomal miR-20a-5p Facilitates HCC Progression via the LIMA1-Mediated β-Catenin Pathway

T. Wang, Wenyong Wu, Haibo Wang, 2022, Cells.

[Expression of Fascin-1 protein in breast cancer and its clinicopathologic correlation].

Yan Wang, Bifei Huang, Chao-Qun Wang, 2014, Zhonghua bing li xue za zhi = Chinese journal of pathology.

TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p

Zhengsheng Wu, Jing Zhang, Benzhong Wang, 2019, Cancer Cell International.

Efficacy and mechanism of osimertinib combined with bevacizumab in the treatment of postoperative EGFR positive stage II-IIIA lung adenocarcinoma.

Yi Wang, Junfeng Gao, Hao Wang, 2022, American journal of translational research.

An alternatively spliced p62 isoform confers resistance to chemotherapy in breast cancer.

T. Zhu, P. Lobie, Sheng Tan, 2022, Cancer research.